DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Referenz

Frederiksen MT, Ainsworth MA, Brynskov J. et al.
Antibodies against infliximab are associated with de novo development of antibodies to adalimumab and therapeutic failure in infliximab-to-adalimumab switchers with IBD.

Inflamm Bowel Dis 2014;
20: 1714-1721

Frederiksen MT, Ainsworth MA, Brynskov J. et al.
Antibodies against infliximab are associated with de novo development of antibodies to adalimumab and therapeutic failure in infliximab-to-adalimumab switchers with IBD.

Inflamm Bowel Dis 2014;
20: 1714-1721

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: